|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Cancer Institute (NCI) |
|---|---|
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00558974 |
Purpose
RATIONALE: Studying the amount of radiation that patients were exposed to during the clean-up following the Chernobyl nuclear accident may help doctors learn more about the risks of developing leukemia, multiple myeloma, and myelodysplasia.
PURPOSE: This clinical trial is studying the effect of radiation exposure on patients with leukemia, multiple myeloma, or myelodysplasia who were clean-up workers after the Chernobyl nuclear power plant accident.
| Condition | Intervention |
|---|---|
|
Leukemia Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes |
Other: questionnaire administration |
| Study Type: | Observational |
| Official Title: | Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident |
| Estimated Enrollment: | 1000 |
| Study Start Date: | July 1996 |
OBJECTIVES:
Primary
Secondary
OUTLINE: Study participants undergo an interview and complete a questionnaire to provide information on personal and family medical histories and occupational exposure to radiation. Participants who are deceased are evaluated via interviews with spouses or other close relatives to obtain medical histories as well as names of co-workers at Chernobyl. Dose estimates of radiation exposure due to the Chernobyl accident or to medical sources of radiation (i.e., CT scans or radiopharmaceuticals) are made during the dosimetry portion of the interview.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
DISEASE CHARACTERISTICS:
AND meets 1 of the following criteria:
Power Plant in northern Ukraine in 1986 AND meets the following criteria:
Not necessarily alive at selection
Matched control patient
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| Ukraine | |
| Research Centre for Radiation Medicine | Recruiting |
| Kiev, Ukraine, 254050 | |
| Contact: Anatoly Romanenko, MD Not Available | |
| Principal Investigator: | Maureen Hatch, PhD | National Cancer Institute (NCI) |
More Information
| Study ID Numbers: | CDR0000566036, NCI-OH96-C-N030 |
| Study First Received: | November 15, 2007 |
| Last Updated: | February 6, 2009 |
| ClinicalTrials.gov Identifier: | NCT00558974 History of Changes |
| Health Authority: | Unspecified |
|
leukemia multiple myeloma myelodysplastic syndromes |
|
Immunoproliferative Disorders Precancerous Conditions Hematologic Diseases Blood Protein Disorders Blood Coagulation Disorders Myelodysplastic Syndromes Vascular Diseases Paraproteinemias |
Hemostatic Disorders Multiple Myeloma Leukemia Preleukemia Hemorrhagic Disorders Bone Marrow Diseases Lymphoproliferative Disorders Neoplasms, Plasma Cell |
|
Disease Immunoproliferative Disorders Neoplasms by Histologic Type Precancerous Conditions Immune System Diseases Hematologic Diseases Blood Protein Disorders Myelodysplastic Syndromes Vascular Diseases Paraproteinemias Hemostatic Disorders |
Multiple Myeloma Leukemia Preleukemia Neoplasms Pathologic Processes Hemorrhagic Disorders Syndrome Cardiovascular Diseases Bone Marrow Diseases Lymphoproliferative Disorders Neoplasms, Plasma Cell |